CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings

Chimeric antigen receptor T (CAR T) cell therapy achieved remarkable success in B-cell leukemia and lymphoma which led to its incorporation in treatment protocols for these diseases. CAR T cell therapy for chronic lymphocytic leukemia (CLL) patients showed less success compared to other malignant tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Todorovic, Zeljko, Todorovic, Dusan, Markovic, Vladimir, Ladjevac, Nevena, Zdravkovic, Natasa, Djurdjevic, Predrag, Arsenijevic, Nebojsa, Milovanovic, Marija, Arsenijevic, Aleksandar, Milovanovic, Jelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139644/
https://www.ncbi.nlm.nih.gov/pubmed/35621683
http://dx.doi.org/10.3390/curroncol29050293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139644/
https://www.ncbi.nlm.nih.gov/pubmed/35621683
http://dx.doi.org/10.3390/curroncol29050293

Ejemplares similares